Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $2.4M | ﹤0.01% |
31,760
+355
| +1% | +$27.1K |
|
3252
PUT
iRhythm Holdings
IRTC
$3.96B
| $2.4M | ﹤0.01% |
23,000
-31,900
| -58% | -$3.83M |
|
3253
Magnachip Semiconductor
MX
$115M
| $2.4M | ﹤0.01% |
214,417
-47,277
| -18% | -$462K |
|
3254
Bloom Energy
BE
$62.1B
| $2.39M | ﹤0.01% |
146,430
-254,214
| -63% | -$4.11M |
|
3255
CALL
Snowflake
SNOW
$114B
| $2.39M | ﹤0.01% |
13,600
+9,600
| +240% | +$1.56M |
|
|
EDR
3256
CALL
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $2.39M | ﹤0.01% |
+100,000
| New | +$2.36M |
|
3257
Fastly Inc
FSLY
$3.67B
| $2.39M | ﹤0.01% |
151,658
-1,112,335
| -88% | -$17M |
|
3258
Cerus
CERS
$534M
| $2.39M | ﹤0.01% |
970,053
-542,812
| -36% | -$1.29M |
|
3259
Inovio Pharmaceuticals
INO
$133M
| $2.38M | ﹤0.01% |
+445,021
| New | +$3.59M |
|
3260
Trustmark
TRMK
$2.69B
| $2.38M | ﹤0.01% |
112,667
+101,313
| +892% | +$2.29M |
|
3261
PUT
Fidelity National Information Services
FIS
$21.4B
| $2.38M | ﹤0.01% |
43,500
+36,700
| +540% | +$2.02M |
|
3262
PUT
Keurig Dr Pepper
KDP
$43.8B
| $2.38M | ﹤0.01% |
76,000
+68,600
| +927% | +$2.25M |
|
3263
PLDT
PHI
$3.92B
| $2.37M | ﹤0.01% |
101,617
+12,868
| +14% | +$290K |
|
3264
Immunic
IMUX
$210M
| $2.37M | ﹤0.01% |
94,580
-31,882
| -25% | -$534K |
|
|
LONA
3265
LeonaBio Inc
LONA
$74.8M
| $2.37M | ﹤0.01% |
80,442
+27,248
| +51% | +$776K |
|
3266
Scansource
SCSC
$1.15B
| $2.37M | ﹤0.01% |
80,257
+52,941
| +194% | +$1.53M |
|
3267
CVB Financial
CVBF
$3.91B
| $2.37M | ﹤0.01% |
178,371
-308,706
| -63% | -$4.26M |
|
3268
Live Oak Bancshares
LOB
$1.86B
| $2.37M | ﹤0.01% |
89,969
+78,074
| +656% | +$1.84M |
|
3269
PUT
Atlassian
TEAM
$48.2B
| $2.37M | ﹤0.01% |
+14,100
| New | +$2.26M |
|
3270
ThredUp
TDUP
$357M
| $2.36M | ﹤0.01% |
967,107
+153,532
| +19% | +$402K |
|
|
MPT
3271
CALL
Medical Properties Trust
MPT
$2.44B
| $2.36M | ﹤0.01% |
254,800
+207,200
| +435% | +$1.75M |
|
3272
State Street SPDR S&P Dividend ETF
SDY
$22B
| $2.36M | ﹤0.01% |
19,241
+7,777
| +68% | +$950K |
|
|
UCB
3273
United Community Banks
UCB
$4.24B
| $2.35M | ﹤0.01% |
94,075
-287,444
| -75% | -$7.13M |
|
|
MPT
3274
PUT
Medical Properties Trust
MPT
$2.44B
| $2.35M | ﹤0.01% |
253,700
+205,900
| +431% | +$1.74M |
|
|
EXAS
3275
CALL
DELISTED
Exact Sciences
EXAS
| $2.35M | ﹤0.01% |
25,000
+9,300
| +59% | +$725K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.